Summary
This prediction ended on 28.12.15 with a price of €116.10. The price of Bayer AG has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.01%. exploration has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | -3.568% | -3.568% | -48.840% | -51.161% |
iShares Core DAX® | -0.205% | 2.949% | 17.330% | 18.203% |
iShares Nasdaq 100 | 1.613% | 5.877% | 37.451% | 56.281% |
iShares Nikkei 225® | -0.740% | -1.256% | 11.847% | 5.531% |
iShares S&P 500 | 0.267% | 3.240% | 29.308% | 46.371% |
Comments by exploration for this prediction
In the thread Bayer AG diskutieren
Bayer: langfristig positiv
Bayer ist für langfristig orientierte Anleger ein Basisinvestment. Somit können Rückschläge bis 130€ für Käufe getätigt werden. Unter 122€ wird es kritisch.